Skip to main content

Advertisement

Log in

Liver Abscess in Chronic Granulomatous Disease—Two Decades of Experience from a Tertiary Care Centre in North-West India

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

Most of the literature on liver abscess in chronic granulomatous disease (CGD) emanates from developed countries. Data from developing countries are scarce. In this study, we report clinical features, microbiological profile, and treatment difficulties encountered while managing liver abscesses in patients with CGD at a tertiary care centre in North-West India.

Methodology

Case records of children with CGD and liver abscesses at Pediatric Immunodeficiency Clinic, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India were analyzed.

Results

Seven of 68 patients (10.29%) with CGD presented with hepatic abscess. One patient had 2 recurrences. All were males and age-range at presentation was 7 months–22 years. Mutation analysis was carried out in all patients—3 had defects in CYBB gene; 2 in NCF1; 2 in NCF2 gene. Staphylococcus aureus was isolated from 5 patients. Duration of antimicrobial treatment ranged from 3 weeks to 7 months. Open drainage was required in 1 patient, and 1 patient was treated with a prolonged course of prednisolone. Two children succumbed to the illness.

Conclusions

This is the largest reported experience of liver abscesses in patients with CGD from the developing world. Staphylococcus aureus was the commonest pathogen isolated. In our experience, prolonged courses of antimicrobials are usually necessary in these patients. Glucocorticoids can reduce inflammatory response and facilitate early resolution of abscesses in CGD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AR:

Autosomal recessive

BAL:

Bronchoalveolar lavage

CECT:

Contrast-enhanced computerized tomography

CGD:

Chronic granulomatous disease

CRP:

C-reactive protein

DHR:

Dihydrorhodamine

ESR:

Erythrocyte sedimentation rate

IUIS:

International Union of Immunological Societies

IV:

Intravenous

MRI:

Magnetic resonance imaging

MRSA:

Methicillin-resistant Staphylococcus aureus

MSSA:

Methicillin-sensitive Staphylococcus aureus

NBT:

Nitro blue tetrazolium test

SI:

Stimulation index

XL:

X-linked

References

  1. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS Phenotypical classification. J Clin Immunol. 2020;40(1):66–81.

    Article  Google Scholar 

  2. Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27(1):89–99.

    Article  Google Scholar 

  3. Roos D. Chronic granulomatous disease. Br Med Bull. 2016 Jun;118(1):50–63.

    Article  Google Scholar 

  4. Seger RA. Modern management of chronic granulomatous disease. Br J Haematol. 2008;140(3):255–66.

    Article  CAS  Google Scholar 

  5. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79(3):170–200.

    Article  CAS  Google Scholar 

  6. van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European Experience. PLoS ONE. 2009;4(4):e5234. https://doi.org/10.1371/journal.pone.0005234.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155–69.

    Article  CAS  Google Scholar 

  8. Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(1):58–67.

    Article  CAS  Google Scholar 

  9. Rawat A, Bhattad S, Singh S. Chronic granulomatous disease. Indian J Pediatr. 2016;83(4):345–53.

    Article  Google Scholar 

  10. Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.

    Article  Google Scholar 

  11. Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–1163.e5.

    Article  Google Scholar 

  12. Jindal AK, Pilania RK, Rawat A, Singh S. Primary immunodeficiency disorders in India-a situational review. Front Immunol. 2017;8:714.

    Article  Google Scholar 

  13. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy CMA. 2011;9(1):10.

    Article  CAS  Google Scholar 

  14. Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatol Baltim Md. 2007;45(3):675–83.

    Article  Google Scholar 

  15. Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60(8):1176–83.

    Article  CAS  Google Scholar 

  16. Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235(3):383–91.

    Article  Google Scholar 

  17. Pilania RK, Arora A, Agarwal A, Jindal AK, Aggarwal K, Krishnan G, et al. Linezolid-induced mitochondrial toxicity presenting as retinal nerve fiber layer microcysts and optic and peripheral neuropathy in a patient with chronic granulomatous disease. Retin Cases Brief Rep. 2018. https://doi.org/10.1097/ICB.0000000000000777.

  18. Pilania RK, Prithvi A, Nambiyar K, Gupta K, Rawat A. Revisiting fatal granulomatous disease of childhood through an autopsy: still lethal in the developing world. J Clin Immunol. 2019;39(3):241–4.

    Article  Google Scholar 

  19. Kulkarni M, Hule G, de Boer M, van Leeuwen K, Kambli P, Aluri J, et al. Approach to molecular diagnosis of chronic granulomatous disease (CGD): an experience from a large cohort of 90 Indian patients. J Clin Immunol. 2018;38(8):898–916.

    Article  CAS  Google Scholar 

  20. Rawat A, Vignesh P, Sharma A, Shandilya JK, Sharma M, Suri D, et al. Infection profile in chronic granulomatous disease: a 23-year experience from a tertiary Care Center in North India. J Clin Immunol. 2017;37(3):319–28.

    Article  Google Scholar 

  21. Gao L, Yin Q, Tong Y, Gui J, Liu X, Feng X, et al. Clinical and genetic characteristics of Chinese pediatric patients with chronic granulomatous disease. Pediatr Allergy Immunol. 2019;30(3):378–86.

    Article  Google Scholar 

  22. Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241–248.e3.

    Article  Google Scholar 

  23. Pilania RK, Chaudhary H, Jindal AK, Rawat A, Singh S. Current status and prospects of primary immunodeficiency diseases in Asia. Genes Dis. 2020;7(1):3–11.

    Article  Google Scholar 

  24. Garcia-Eulate R, Hussain N, Heller T, Kleiner D, Malech H, Holland S, et al. CT and MRI of hepatic abscess in patients with chronic granulomatous disease. Am J Roentgenol. 2006;187(2):482–90.

    Article  Google Scholar 

  25. Chen LE, Minkes RK, Shackelford PG, Strasberg SM, Kuo EY, Langer JC. Cut it out: managing hepatic abscesses in patients with chronic granulomatous disease. J Pediatr Surg. 2003;38(5):709–13.

    Article  Google Scholar 

  26. Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El-Khateeb MS, Al-Wahadneh AM, et al. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol. 2009;29(2):215–30.

    Article  Google Scholar 

  27. Kiat MO, Boisson-Dupuis S, Casanova JL, Bustamante J, Gepte MBP, Santos JA. Chronic granulomatous disease: unreported mutation. PIDSP. 2017;18(1):45–53.

    Google Scholar 

  28. Shin K-S, Lee MS. Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease. Korean J Pediatr. 2016;59(4):196–201.

    Article  Google Scholar 

  29. Leiding JW, Freeman AF, Marciano BE, Anderson VL, Uzel G, Malech HL, et al. Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis. 2012;54(5):694–700.

    Article  CAS  Google Scholar 

  30. Straughan DM, McLoughlin KC, Mullinax JE, Marciano BE, Freeman AF, Anderson VL, et al. The changing paradigm of management of liver abscesses in chronic granulomatous disease. Clin Infect Dis. 2018;66(9):1427–34.

    Article  CAS  Google Scholar 

  31. Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, Hernandez-Bautista V, Espinosa-Rosales F. Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2006;97(2):257–61.

    Article  CAS  Google Scholar 

  32. Conte D, Fraquelli M, Capsoni F, Giacca M, Zentilin L, Bardella MT. Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. J Interf Cytokine Res. 1999;19(7):705–10.

    Article  CAS  Google Scholar 

  33. The International Chronic Granulomatous Disease Cooperative Study Group*. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324(8):509–16.

    Article  Google Scholar 

  34. Slack MA, Thomsen IP. Prevention of infectious complications in patients with chronic granulomatous disease. J Pediatr Infect Dis Soc. 2018;7(suppl_1):S25–30.

    Article  Google Scholar 

Download references

Acknowledgments

We sincerely thank the patients and their parents for their cooperation.

Disclaimer

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Funding

This study is funded by the Indian Council of Medical Research, New Delhi and Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi Grant No GIA/48/2014-DHR to SS, and The Foundation for Primary Immunodeficiencies (FPID), USA.

YLL was supported by The Society for Relief of Disabled Children for genetic sequencing.

Author information

Authors and Affiliations

Authors

Contributions

RKP and AR designed the research.

RKP, AR, PV, GD, SS, AKJ, GD, DS, AG, KG, KWC, YLL, KI, and SS performed the research.

RKP, AR, PV, and SS wrote the paper.

AR, KWY, YLL, and KI performed the genetic analysis of these patients.

KG performed histopathological examination. AR and SS critically supervised the manuscript.

All the authors read and approve the final manuscript.

Corresponding author

Correspondence to Amit Rawat.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest

Ethical Approval

This study was approved by Departmental Review Board at the Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Supplementary Figure 1

Course of illness in case 1 (Abbreviations: CGD: Chronic granulomatous disease; IV: Intravenous; MSSA: Methicillin sensitive Staphylococcus aureus; MRSA; Methicillin resistant Staphylococcus aureus; USG: Ultrasonogram) (JPG 145 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pilania, R.K., Rawat, A., Vignesh, P. et al. Liver Abscess in Chronic Granulomatous Disease—Two Decades of Experience from a Tertiary Care Centre in North-West India. J Clin Immunol 41, 552–564 (2021). https://doi.org/10.1007/s10875-020-00938-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00938-9

Keywords

Navigation